In comparison, a subset of our Flt3+/ITD/Wt1+/R394W mice developed AML, including one mouse with LOH of Flt3. Overall, there is mounting evidence for the role of disrupted WT1 function contributing to the development of hematologic malignancies. This evidence concerns the gene WT1 and hematologic disorder.